FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation

FRA:FME • DE0005785802

39.99 EUR
+0.48 (+1.21%)
Last: Mar 4, 2026, 12:59 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to FME. FME was compared to 30 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. FME is valued correctly, but it does not seem to be growing. Finally FME also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. FME.DE Profitability Analysis

1.1 Basic Checks

  • In the past year FME was profitable.
  • In the past year FME had a positive cash flow from operations.
  • FME had positive earnings in 4 of the past 5 years.
  • FME had a positive operating cash flow in 4 of the past 5 years.
FME.DE Yearly Net Income VS EBIT VS OCF VS FCFFME.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.33%, FME is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • FME has a Return On Equity (5.55%) which is comparable to the rest of the industry.
  • FME has a Return On Invested Capital of 3.95%. This is comparable to the rest of the industry: FME outperforms 43.33% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for FME is below the industry average of 6.83%.
  • The last Return On Invested Capital (3.95%) for FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROIC 3.95%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
FME.DE Yearly ROA, ROE, ROICFME.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • FME's Profit Margin of 3.66% is fine compared to the rest of the industry. FME outperforms 73.33% of its industry peers.
  • FME's Profit Margin has declined in the last couple of years.
  • With a Operating Margin value of 7.19%, FME perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of FME has declined.
  • FME's Gross Margin of 25.00% is in line compared to the rest of the industry. FME outperforms 60.00% of its industry peers.
  • In the last couple of years the Gross Margin of FME has declined.
Industry RankSector Rank
OM 7.19%
PM (TTM) 3.66%
GM 25%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
FME.DE Yearly Profit, Operating, Gross MarginsFME.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. FME.DE Health Analysis

2.1 Basic Checks

  • FME has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for FME. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FME.DE Yearly Shares OutstandingFME.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
FME.DE Yearly Total Debt VS Total AssetsFME.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • FME has an Altman-Z score of 2.18. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
  • FME's Altman-Z score of 2.18 is fine compared to the rest of the industry. FME outperforms 66.67% of its industry peers.
  • FME has a debt to FCF ratio of 5.97. This is a neutral value as FME would need 5.97 years to pay back of all of its debts.
  • FME's Debt to FCF ratio of 5.97 is fine compared to the rest of the industry. FME outperforms 73.33% of its industry peers.
  • A Debt/Equity ratio of 0.73 indicates that FME is somewhat dependend on debt financing.
  • FME has a better Debt to Equity ratio (0.73) than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Altman-Z 2.18
ROIC/WACC0.69
WACC5.75%
FME.DE Yearly LT Debt VS Equity VS FCFFME.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.3 Liquidity

  • FME has a Current Ratio of 1.36. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
  • FME has a better Current ratio (1.36) than 70.00% of its industry peers.
  • A Quick Ratio of 1.00 indicates that FME may have some problems paying its short term obligations.
  • FME's Quick ratio of 1.00 is fine compared to the rest of the industry. FME outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1
FME.DE Yearly Current Assets VS Current LiabilitesFME.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. FME.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 9.36% over the past year.
  • FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.15% yearly.
EPS 1Y (TTM)9.36%
EPS 3Y4.66%
EPS 5Y-5.15%
EPS Q2Q%-22.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.52%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.40% on average over the next years. This is quite good.
  • FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.79% yearly.
EPS Next Y16.67%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
EPS Next 5Y12.4%
Revenue Next Year2.15%
Revenue Next 2Y3.14%
Revenue Next 3Y4.72%
Revenue Next 5Y3.79%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FME.DE Yearly Revenue VS EstimatesFME.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FME.DE Yearly EPS VS EstimatesFME.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. FME.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • FME is valuated reasonably with a Price/Earnings ratio of 11.26.
  • FME's Price/Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 86.67% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of FME to the average of the S&P500 Index (26.83), we can say FME is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 9.64, the valuation of FME can be described as very reasonable.
  • FME's Price/Forward Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 90.00% of the companies in the same industry.
  • FME's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.95.
Industry RankSector Rank
PE 11.26
Fwd PE 9.64
FME.DE Price Earnings VS Forward Price EarningsFME.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FME is on the same level as its industry peers.
  • FME's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 13.37
EV/EBITDA 10.35
FME.DE Per share dataFME.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • FME's earnings are expected to grow with 16.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y16.28%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. FME.DE Dividend Analysis

5.1 Amount

  • FME has a Yearly Dividend Yield of 3.67%. Purely for dividend investing, there may be better candidates out there.
  • FME's Dividend Yield is rather good when compared to the industry average which is at 1.55. FME pays more dividend than 96.67% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, FME pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

  • The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
FME.DE Yearly Dividends per shareFME.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • FME pays out 58.83% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
FME.DE Yearly Income VS Free CF VS DividendFME.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
FME.DE Dividend Payout.FME.DE Dividend Payout, showing the Payout Ratio.FME.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FME.DE Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE AG

FRA:FME (3/4/2026, 12:59:45 PM)

39.99

+0.48 (+1.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners43.91%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.47B
Revenue(TTM)N/A
Net Income(TTM)718.19M
Analysts65.93
Price Target45.79 (14.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.71%
PT rev (3m)-5.47%
EPS NQ rev (1m)12.25%
EPS NQ rev (3m)14.55%
EPS NY rev (1m)0%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 11.26
Fwd PE 9.64
P/S 1.19
P/FCF 13.37
P/OCF 9.35
P/B 1.81
P/tB N/A
EV/EBITDA 10.35
EPS(TTM)3.55
EY8.88%
EPS(NY)4.15
Fwd EY10.37%
FCF(TTM)2.99
FCFY7.48%
OCF(TTM)4.28
OCFY10.7%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.68
PEG (5Y)N/A
Graham Number41.98
Profitability
Industry RankSector Rank
ROA 2.33%
ROE 5.55%
ROCE 5.62%
ROIC 3.95%
ROICexc 4.26%
ROICexgc 11.65%
OM 7.19%
PM (TTM) 3.66%
GM 25%
FCFM 8.93%
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 5.97
Debt/EBITDA 3.12
Cap/Depr 47.15%
Cap/Sales 3.85%
Interest Coverage 3.87
Cash Conversion 83.24%
Profit Quality 244.33%
Current Ratio 1.36
Quick Ratio 1
Altman-Z 2.18
F-Score5
WACC5.75%
ROIC/WACC0.69
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)9.36%
EPS 3Y4.66%
EPS 5Y-5.15%
EPS Q2Q%-22.61%
EPS Next Y16.67%
EPS Next 2Y15.11%
EPS Next 3Y16.28%
EPS Next 5Y12.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-1.52%
Revenue Next Year2.15%
Revenue Next 2Y3.14%
Revenue Next 3Y4.72%
Revenue Next 5Y3.79%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.05%
EBIT Next 3Y28.86%
EBIT Next 5Y18.07%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%

FRESENIUS MEDICAL CARE AG / FME.DE FAQ

What is the fundamental rating for FME stock?

ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.


What is the valuation status for FME stock?

ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?

FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.


What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 11.26 and the Price/Book (PB) ratio is 1.81.


How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?

The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 58.83%.